Skip to content

Theriva Biologics, Inc.

TOVX· NYSECore metricsCIK 894158

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -1.05%
Market cap
$7.37M
45.89M shares
Filings
1,013
$300.00K
Q3 2026−100.0% FY11 yoy
-$1.47M
Q3 2026N/M FY25 yoy
-$1.54M
Q3 2026N/M FY25 yoy
-$8.41M
Q3 2026derivedN/M FY25 yoy
-$0.03
Q3 2026N/M FY25 yoy
$8.47M
Q3 2026+12.5% FY25 yoy
$7.37M
—
—
0.7×
-226.64%
—

FY2025 figures · derived

Price

$0.160641.85%$0.1156past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2011
$2.61M0FY 2010FY 2011
PeriodEndedValueKindSource trail
FY 20112011-12-31$0reported
FY 20102010-12-31$2,614,000reported

Capital returns

Dividends and buybacks · FY2009 to FY2023
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2023—$0.00$0.00—17.15M sh+13.4%—
FY2022—$288.00K$288.00K—15.12M sh−90.5%—
FY2021—$0.00$0.00—158.44M sh+22.2%—
FY2009—$1.00M$1.00M————

Segments

Geography
Long-lived assets by Geography, FY2024 to FY2025FY2024UNITED STATES · FY2024 · $53.00KSpain · FY2024 · $216.00KFY2025UNITED STATES · FY2025 · $610.00KSpain · FY2025 · $415.00K
LineFY2025ShareChange
UNITED STATES$610.00K275%+1,050.9%
Spain$415.00K187%+92.1%
Total$222.00K

From the 10-Q filed Nov 12, 2026TOVX

Pharmaceutical preparations

Theriva Biologics, Inc. is the 434th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Theriva Biologics, Inc. · CIK 894158 · Engraved from SEC EDGAR